To determine the cross-species reactivity of anti-PD-L1 shark VNARs against native PD-L1, three PD-L1-positive tumor cell lines, including a human breast cancer cell line, a mouse melanoma cell line, and a canine melanoma cell line, were used to evaluate the binding ability of B2, A11, and F5. This evidence concerns the gene CD274 and breast carcinoma.